P. Friden

发表

Photoactive Porphyrin Derivative with Broad-Spectrum Activity against Oral Pathogens In Vitro

C. Rovaldi, A. Pievsky, N. Solé, 2000, Antimicrobial Agents and Chemotherapy.

Transferrin-antibody fusion proteins are effective in brain targeting.

S. Morrison, T. Olson, W. Pardridge, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

R. Starzyk, P. Friden, B. Malfroy, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Delivery of Trophic Factors to the Primate Brain

A. Granholm, E. Mufson, J. Kordower, 1993, Experimental Neurology.

Blood-brain barrier penetration and in vivo activity of an NGF conjugate.

F. Bloom, B. Hoffer, C. Bäckman, 1993, Science.

Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease.

J. Kordower, R. Bartus, V. Charles, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Systemic Administration of a Nerve Growth Factor Conjugate Reverses Age-Related Cognitive Dysfunction and Prevents Cholinergic Neuron Atrophy

A. Granholm, R. Bartus, B. Hoffer, 1996, The Journal of Neuroscience.

Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies.

R. Starzyk, W. Pardridge, P. Friden, 1996, The Journal of pharmacology and experimental therapeutics.

Transcytosis of Protein through the Mammalian Cerebral Epithelium and Endothelium III. Receptor-Mediated Transcytosis through the Blood–Brain Barrier of Blood-Borne Transferrin and Antibody against the Transferrin Receptor

R. Broadwell, C. Oliver, P. Friden, 1996, Experimental Neurology.

Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7

R. Bartus, P. Friden, M. Brightman, 1995, Brain Research.

Effects of transferrin receptor antibody—NGF conjugate on young and aged septal transplants in oculo

I. Strömberg, C. Bäckman, P. Friden, 1995, Experimental Neurology.

Utilization of an endogenous cellular transport system for the delivery of therapeutics across the blood–brain barrier

P. Friden, 1997 .

Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.

S. N. Murthy, P. Friden, Aditya K. Gupta, 2009, Journal of pharmaceutical sciences.

Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate

P. Friden, A. Banga, V. Vemulapalli, 2008, The Journal of pharmacy and pharmacology.

Peripheral Administration of Nerve Growth Factor Conjugated to an Anti-transferrin Receptor Antibody Increases Cholinergic Neuron Survival in Intraocular Forebrain Transplants

A. Granholm, G. Gerhardt, L. Olson, 1994 .

Receptor-mediated transport of therapeutics across the blood-brain barrier.

P. Friden, 1994, Neurosurgery.

6 – Ferrotransferrin and Antibody against the Transferrin Receptor as Potential Vehicles for Drug Delivery across the Mammalian Blood-Brain Barrier into the Central Nervous System

W. Banks, R. Broadwell, C. Oliver, 1994 .

Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

W. Pardridge, P. Friden, J. Buciak, 1991, The Journal of pharmacology and experimental therapeutics.

Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.

R. Obar, T. Olson, P. Friden, 1996, The Journal of pharmacology and experimental therapeutics.

Transport of proteins across the blood-brain barrier via the transferrin receptor.

P. Friden, L. Walus, 1993, Advances in experimental medicine and biology.

Antimicrobial activity of silver nitrate against periodontal pathogens.

P. Friden, D. Rothstein, P. Spacciapoli, 2001, Journal of periodontal research.

Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: quantification of the drug localized in skin

P. Friden, A. Banga, Hyun D. Kim, 2009, Journal of drug targeting.

Recovering Ga(III) from coordination complexes using pyridine 2,6-dicarboxylic acid chelation ion chromatography.

X. Kong, P. Friden, R. Hider, 2010, Biomedical chromatography : BMC.

In vivo iontophoretic delivery of salmon calcitonin across microporated skin.

P. Friden, S. Davis, H. Kalluri, 2012, Journal of pharmaceutical sciences.

Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.

P. Friden, A. Banga, V. Sachdeva, 2012, Therapeutic delivery.

Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins.

P. Friden, D. Paquette, R. Williams, 1997, Journal of clinical periodontology.

A Non-invasive System for Delivering Neural Growth Factors across the Blood-Brain Barrier: A Review

A. Granholm, M. Curtis, J. Kordower, 1998, Reviews in the neurosciences.

Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride.

P. Friden, A. Banga, V. Sachdeva, 2010, International journal of pharmaceutics.

An Ex Vivo Toe Model Used to Assess Applicators for the Iontophoretic Ungual Delivery of Terbinafine

P. Friden, S. Davis, Anroop B Nair, 2009, Pharmaceutical Research.

Trans-ungual iontophoretic delivery of terbinafine.

S. N. Murthy, P. Friden, Anroop B Nair, 2009, Journal of pharmaceutical sciences.

Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.

P. Friden, A. Banga, V. Sachdeva, 2010, International journal of pharmaceutics.

Histatin-derived peptides: potential agents to treat localised infections

P. Friden, D. Rothstein, P. Spacciapoli, 2002, Expert opinion on emerging drugs.

Safety and clinical effects of topical histatin gels in humans with experimental gingivitis.

P. Friden, D. Paquette, R. Williams, 2002, Journal of clinical periodontology.

Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.

S. N. Murthy, P. Friden, Anroop B Nair, 2009, International journal of pharmaceutics.

Iontophoretic Delivery of Acyclovir: Intradermal Drug Monitoring Using Microdialysis and Quantification by Skin Extraction

P. Friden, A. Banga, V. Sachdeva, 2011, PDA Journal of Pharmaceutical Science and Technology.

Novel periodontal drug delivery system for treatment of periodontitis.

L. Bromberg, P. Friden, D. Buxton, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Sustained release of silver from periodontal wafers for treatment of periodontitis.

L. Bromberg, P. Friden, D. Rothstein, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Transdermal delivery of proteins using a combination of iontophoresis and microporation.

P. Friden, A. Banga, V. Sachdeva, 2014, Therapeutic delivery.

Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis: a phase-2 multi-center study.

J. Massaro, P. Friden, D. Paquette, 2002, Journal of clinical periodontology.

Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis.

C. McManus, P. Friden, S. Dibart, 2001, Journal of clinical periodontology.

Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5

P. Friden, D. Rothstein, P. Spacciapoli, 2001, Antimicrobial Agents and Chemotherapy.

Synthesis, in vitro kinetics, and in vivo studies on protein conjugates of AZT: evaluation as a transport system to increase brain delivery.

P. Friden, L. Walus, G. Musso, 1993, Bioconjugate chemistry.

P-113d, an Antimicrobial Peptide Active againstPseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients

C. Rovaldi, N. Solé, P. Friden, 2001, Antimicrobial Agents and Chemotherapy.

Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate

E. Mufson, J. Kordower, R. Bartus, 1996, Brain Research.

Acyclovir skin depot characterization following in vivo iontophoretic delivery

P. Friden, A. Banga, V. Sachdeva, 2011, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations.

P. Friden, G. Stagni, Chinmay G. Shukla, 2009, Journal of pharmaceutical sciences.

Phase 1 evaluation of a local delivery device releasing silver ions in periodontal pockets: safety, pharmacokinetics and bioavailability.

N. Lang, P. Friden, M. Tonetti, 2001, Journal of periodontal research.

Acute application of NGF increases the firing rate of aged rat basal forebrain neurons

C. Bäckman, P. Friden, G. Rose, 1999, The European journal of neuroscience.

Drug delivery to the brain using an anti-transferrin receptor antibody.

R. Starzyk, P. Friden, J. Eckman, 1992, NIDA research monograph.

P-113 D , an Antimicrobial Peptide Active against Pseudomonas aeruginosa , Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients

C. Rovaldi, N. Solé, P. Friden, 2001 .

LEU3 of Saccharomyces cerevisiae activates multiple genes for branched-chain amino acid biosynthesis by binding to a common decanucleotide core sequence

P. Schimmel, P. Friden, P Schimmel, 1988, Molecular and cellular biology.